Pick 2–10 funds, stocks or ETFs to see their returns, risk, costs and highlights on one page
| Fund | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| NTRA | +80.85% | +2.56% | +5.30% | +0.24% | +53.64% | +100.96% | +114.42% | +1,003.33% | +1,111.40% |
| ES-GENOME | +68.37% | +5.46% | +3.45% | −6.39% | +31.06% | +64.75% | +60.68% | +91.11% | +37.48% |
| SCBGENOME(SSFE) | +84.74% | +12.69% | +9.85% | +1.47% | +37.00% | +74.82% | +80.34% | +126.39% | +57.57% |
| BCARE | +15.51% | +1.80% | +5.35% | +6.78% | +7.18% | +17.90% | +24.01% | +36.89% | +30.77% |
| SCBRMGHC | +10.74% | +2.25% | +5.00% | +6.38% | +3.73% | +14.65% | +20.10% | +47.97% | +49.19% |
* Fewer than 12 months: the year the fund started reporting NAV, or the current year
Counts only the top holdings with available data, not the whole portfolio · Pick a pair below for details
Excludes NTRA: money market or bond funds, or no holdings data yet
| ES-GENOME | SCBGENOME(SSFE) | |
|---|---|---|
| Held by both | ||
 Twist Bioscience | 10.83% | 10.03% |
 10x Genomics | 10.50% | 8.02% |
 Tempus AI | 9.36% | 7.15% |
 CRISPR Therapeutics | 5.49% | 4.20% |
 Absci | 5.30% | 4.05% |
| Personalis | 5.12% | 3.91% |
 Guardant Health | 4.83% | 3.69% |
 Natera | 4.75% | 3.63% |
 Illumina | 4.71% | 3.60% |
 CareDx | 4.55% | 3.48% |
30 Dec 2025 → 30 Oct 2026
| Fund | Return per year | Volatility per year | Sharpe |
|---|---|---|---|
| SCBGENOME(SSFE) | +84.74% | 41.93% | 2.02 |
| ES-GENOME | +68.37% | 42.41% | 1.61 |
| NTRA | +80.85% | 51.97% | 1.56 |
| BCARE | +15.51% | 15.99% | 0.97 |
| SCBRMGHC | +10.74% | 16.87% | 0.64 |
Sharpe here = annual return ÷ annual volatility, without deducting the risk-free rate, calculated from NAV over the selected period · Periods shorter than 1 year use the cumulative return instead of the annual return
| Drag a column header to reorder | NTRA | ES-GENOME | SCBGENOME(SSFE) | BCARE | SCBRMGHC |
|---|---|---|---|---|---|
Fund details | |||||
| Fund size | N/A | 222 million | 3.27 million | 4,742 million | 2,422 million |
| Inception date | N/A | 23 Mar 2021 | 20 Aug 2021 | 29 Aug 2007 | 6 Nov 2015 |
| Master fund | N/A | กองทุนที่ลงทุนหลายกอง (ARK Genomic Revolution UCITS, ARK Genomic Revolution, iShares Genomics Immunology and Healthcare) | กองทุน ARK Genomic Revolution ETF | Wellington Global Health Care Equity Fund | Janus Henderson Global Life Sciences Fund |
| Dividend policy | N/A | Does not pay | Pays | Does not pay | Does not pay |
Risk and currency hedging | |||||
| Risk level | N/A | 7 | 7 | 7 | 7 |
| Hedging policy | N/A | Hedged at the manager's discretion | Hedged at the manager's discretion | Hedged at the manager's discretion | Almost fully hedged |
| Share hedged | N/A | 79.06% | 57.68% | 47.41% | 100.58% |
Minimum purchase and redemption | |||||
| First purchase | N/A | 1 THB | 1 THB | 500 THB | 1,000 THB |
| Subsequent purchase | N/A | 1 THB | 1 THB | 500 THB | 1,000 THB |
| Redemption (amount) | N/A | 1 THB | No minimum | No minimum | 1,000 THB |
| Redemption (units) | N/A | 1 units | No minimum | No minimum | No minimum |
| Balance (amount) | N/A | No minimum | No minimum | No minimum | 1,000 THB |
| Balance (units) | N/A | No minimum | No minimum | No minimum | No minimum |
Order cut-off and redemption payment | |||||
| Buy before | N/A | 15:30 | 15:30 | 15:30 | 15:30 |
| Redeem before | N/A | 15:30 | 15:30 | 15:30 | 15:30 |
| Redemption paid | N/A | T+4 | T+4 | T+4 | T+5 |
